[Federal Register Volume 81, Number 199 (Friday, October 14, 2016)]
[Notices]
[Pages 71107-71108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24808]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders in Newborns and 
Children

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App.), notice is 
hereby given that a meeting is scheduled for the Advisory Committee on 
Heritable Disorders in Newborns and Children. This meeting will be open 
to the public but advance registration is required to ensure sufficient 
webinar capacity. The registration link is https://www.blsmeetings.net/achdncnovember2016/. The registration deadline is Wednesday, November 
2, 2016, 11:59 p.m. Eastern Time.

DATES AND TIMES: November 3, 2016, 9:00 a.m. to 5:00 p.m. (Meeting time 
is tentative.)
    November 4, 2016, 9:00 a.m. to 1:00 p.m. (Meeting time is 
tentative.)

ADDRESSES: This meeting will be held by webinar only.

FOR FURTHER INFORMATION CONTACT: Anyone interested in obtaining other 
relevant information should contact Alaina Harris, Maternal and Child 
Health Bureau, HRSA, Room 18W66, 5600 Fishers Lane, Rockville, Maryland 
20857; email: [email protected].

SUPPLEMENTARY INFORMATION: The Advisory Committee on Heritable 
Disorders in Newborns and Children (Committee), as authorized by the 
Public Health Service Act, Title XI, Sec.  1111 (42 U.S.C. 300b-10), 
was established to advise the Secretary of the Department of Health and 
Human Services about the development of newborn screening activities, 
technologies, policies, guidelines, and programs for effectively 
reducing morbidity and mortality in newborns and children having, or at 
risk for, heritable disorders. In addition, the Committee's 
recommendations regarding additional conditions/inherited disorders for 
screening that have been adopted by the Secretary are included in the 
Recommended Uniform Screening Panel and constitute part of the 
comprehensive guidelines supported by HRSA. Pursuant to section 2713 of 
the Public Health Service Act, codified at 42 U.S.C. 300gg-13, non-
grandfathered health plans are required to cover screenings included in 
the HRSA-supported comprehensive guidelines without charging a co-
payment, co-insurance, or deductible for plan years (i.e., policy 
years) beginning on or after the date that is 1-year from the 
Secretary's adoption of the condition for screening.
    The Committee will hear presentations and discussions on topics 
related to newborn screening activities, technologies, policies, 
guidelines, and programs for effectively reducing morbidity and 
mortality in newborns and children having, or at risk for, heritable 
disorders. The Committee will also hear updates from the Laboratory 
Standards and Procedures workgroup, Follow-up and Treatment workgroup, 
and Education and Training workgroup. Agenda items are subject to 
changes as priorities indicate. Tentatively, the Committee is expected 
to review and/or vote on the following: Approving newborn screening 
surveillance case definitions and whether or not the nominated 
condition Guanidinoacetate Methyltransferase deficiency should be 
referred for a full evidence-based review. The Committee will not be 
voting on a proposed addition of a condition to the Recommended Uniform 
Screening Panel. The meeting agenda will be available 2 days prior to 
the meeting on the Committee's Web site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
    Members of the public may submit written and/or present oral 
comments at the meeting. All comments are part of the official 
Committee record. Advance registration is required to submit written 
comments and/or present oral comments. Written comments must be 
submitted by October 19, 2016, 11:59 p.m. Eastern Time in order to be 
included in the November meeting briefing book. Written comments should 
identify the individual's name, address, email, telephone number, 
professional or business affiliation, type of expertise (i.e., parent, 
researcher, clinician, public health, etc.), and the topic/subject 
matter of comments.
    Individuals who wish to provide oral comments must register by 
October 30, 2016, 11:59 p.m. Eastern Time. To ensure that all 
individuals who have registered to make oral comments can be 
accommodated, the allocated time may

[[Page 71108]]

be limited. Individuals who are associated with groups or have similar 
interests may be requested to combine their comments and present them 
through a single representative. No audiovisual presentations are 
permitted.
    More information on the Advisory Committee is available at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.

Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-24808 Filed 10-13-16; 8:45 am]
 BILLING CODE 4165-15-P